Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma

Journal of Clinical Oncology

Volumn 28, Issue 5, 2010, Pages 847-852

  Voit, Christiane ^a   Van Akkooi, Alexander C J ^a   Schäfer Hesterberg, Gregor ^a   Schoengen, Alfred ^a   Kowalczyk, Katharina ^a   Roewert, Joachim C ^a   Sterry, Wolfram ^a   Eggermont, Alexander M M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; TUMOR VOLUME; ULTRASOUND; CANCER STAGING; DATA BASE; DOPPLER FLOWMETRY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; KAPLAN MEIER METHOD; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PATIENT SELECTION; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME;

BIOPSY, FINE-NEEDLE; DATABASES AS TOPIC; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77649224567     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.7428     Document Type: Article

References (31)

1. Buzzell RA, Zitelli JA: Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol 34:798-803, 1996 (Pubitemid 26137206)
2. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
3. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
4. Morton DL, Thompson JF, Cochran AJ, et al: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307-1317, 2006 (Pubitemid 44465459)
5. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1995
6. Albertini JJ, Cruse CW, Rapaport D, et al: Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217-224, 1996 (Pubitemid 26065217)
7. Gershenwald JE, Thompson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976-983, 1999 (Pubitemid 29109331)
8. Rossi CR, Seno A, Vecchiato A, et al: The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur J Cancer 33:200-203, 1997 (Pubitemid 27117714)
9. Voit C, Mayer T, Kron M, et al: Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91:2409-2416, 2001 (Pubitemid 32552829)
10. Voit C, Kron M, Schafer G, et al: Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 13:1682-1689, 2006 (Pubitemid 44951477)
11. Voit CA, van Akkooi ACJ, Schaefer-Hesterberg G, et al: Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration (FNAC) cytology: Can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol 27:4994-5000, 2009
12. Voit CA, Schafer-Hesterberg G, Kron M, et al: Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival. J Clin Oncol 26:5742-5747, 2008
13. van Akkooi A, de Wilt J, Verhoef C, et al: Clinical relevance of melanoma micrometastases (< 0.1 mm) in sentinel nodes: Are these nodes to be considered negative? Ann Oncol 17:1578-1585, 2006
14. van Akkooi AC, Nowecki ZI, Voit C, et al: Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: A multicenter study in 388 patients with positive sentinel nodes. Ann Surg 248:949-955, 2008
15. Dewar DJ, Newell B, Green MA, et al: The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22:3345-3349, 2004 (Pubitemid 41103692)
16. Schoengen A, Binder T, Faiss S, et al: Fine needle aspiration cytology of metastatic malignant melanoma: Improvement of results with ultrasound control [German]. Hautarzt 44:703-707, 1993
17. Vassallo P, Wernecke K, Roos N, et al: Differentiation of benign from malignant superficial lymphadenopathy: The role of high-resolution US. Radiology 183:215-220, 1992
18. Vassallo P, Edel G, Roos N, et al: In-vitro high-resolution ultrasonography of benign and malignant lymph nodes: A sonographic-pathologic correlation. Invest Radiol 28:698-705, 1993 (Pubitemid 24081767)
19. Thomas JM: Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 5:18-23, 2008 (Pubitemid 351512425)
20. van Akkooi AC, de Wilt JH, Voit C, et al: Sentinel lymph-node false positivity in melanoma. Nat Clin Pract Oncol 5:E2, 2008
21. Kahle B, Hoffend J, Wacker J, et al: Preoperative ultrasonographic identification of the sentinel lymph node in patients with malignant melanoma. Cancer 97:1947-1954, 2003
22. Voit C, Mayer T, Proebstle TM, et al: Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 90:186-193, 2000 (Pubitemid 30438952)
23. Uren RF, Howman-Giles R, Thompson JF, et al: High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol 43:148-152, 1999 (Pubitemid 29260073)
24. Uren RF, Sanki A, Thompson JF: The utility of ultrasound in patients with melanoma. Expert Rev Anticancer Ther 7:1633-1642, 2007
25. Solivetti FM, Di Luca SA, Pirozzi G, et al: Sonographic evaluation of clinically occult in-transit and satellite metastases from cutaneous malignant melanoma. Radiol Med (Torino) 111:702-708, 2006 (Pubitemid 44426754)
26. Morton DL, Cochran AJ, Thompson JF: The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 5:510-511, 2008
27. Leboulleux S, Girard E, Rose M, et al: Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590-3594, 2007 (Pubitemid 47435339)
28. Deurloo EE, Tanis PJ, Gilhuijs KG, et al: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39:1068-1073, 2003 (Pubitemid 36555863)
29. Rossi CR, Mocellin S, Scagnet B, et al: The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 83:80-84, 2003 (Pubitemid 36667415)
30. Starritt EC, Uren RF, Scolyer RA, et al: Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 12:18-23, 2005
31. van Rijk MC, Teertstra HJ, Peterse JL, et al: Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol 13:1511-1516, 2006 (Pubitemid 44749663)